Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03571919

Lidocaine Infusions for Rib Fractures

Efficacy of Intravenous Lidocaine Infusion for Traumatic Rib Fracture Pain Control

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with traumatic rib fractures not receiving regional anesthesia through a epidural or nerve block catheter will be recruited for the study. Once enrolled, they will be randomized to receive either intravenous lidocaine or intravenous saline for control of pain related to their rib fractures. In addition, they will receive other pain medications, such as acetaminophen, gabapentin, and opioid pain medications. Our primary outcome is a decrease in their opioid medication requirements.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine infusionIntravenous bolus of lidocaine (1.25 mg/kg) and then infusion at 1 mg/kg/hr
DRUGSaline infusionIntravenous bolus of saline and then infusion

Timeline

Start date
2018-06-15
Primary completion
2019-06-01
Completion
2019-07-01
First posted
2018-06-28
Last updated
2021-06-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03571919. Inclusion in this directory is not an endorsement.